Company Profile
TransMedics Stock Price, News & Catalysts
- Ticker:
- TMDX
- Exchange:
- NASDAQ
- Sector:
- MedTech
- Location:
- United States
Stock performance
78.64 USD (-5.76%)
Close
Last updated: October 1, 2026
2.37B USD
Market cap
Why the stock is moving
As of Oct 1, 2026, TMDX closed down 5.76% at $78.64. No new same-company headline was identified in the current news window.
Company overview
Organ Transplant Technology Company
TransMedics develops technology and services intended to expand access to donor organs for patients with end-stage heart, lung, and liver failure.
Organ Care System
The Organ Care System uses portable extracorporeal warm perfusion to preserve donor organs in a functioning state outside the body. The platform also allows clinicians to assess organ condition before transplantation.
Heart, Lung, and Liver Applications
Separate OCS configurations support donor hearts, lungs, and livers. The technology is designed to reduce the limitations of static cold storage and enable the use of organs that might otherwise be declined.
National OCS Program
The National OCS Program provides a coordinated service that includes trained clinical specialists, logistics, and OCS deployment. This turnkey model helps transplant centers access the technology without building every operational capability internally.
Integrated Aviation and Development Pipeline
TransMedics is building dedicated aviation and logistics capacity in the United States and Europe to transport organs and clinical teams. Development investments include OCS Kidney, next-generation OCS technology, and clinical programs intended to expand the platform.
Future catalysts
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of TransMedics (TMDX)?
TransMedics (TMDX) most recently closed at 78.64 USD, a -5.76% move versus the previous session.
What is the market cap of TransMedics (TMDX)?
TransMedics currently has a market capitalization of 2.37B USD on BioPharmSignal.
What does TransMedics do?
Organ Transplant Technology Company TransMedics develops technology and services intended to expand access to donor organs for patients with end-stage heart, lung, and liver failure. Organ Care System The Organ Care System uses portable extracorporeal warm perfusion to preserve donor organs in a functioning state outside the body. The platform also allows...
On which exchange is TMDX stock listed?
TransMedics (TMDX) is associated with NASDAQ, United States, MedTech.
What is Organ?
Organ Transplant Technology Company TransMedics develops technology and services intended to expand access to donor organs for patients with end-stage heart, lung, and liver failure.
Which conditions is TransMedics targeting with Organ?
Organ Transplant Technology Company TransMedics develops technology and services intended to expand access to donor organs for patients with end-stage heart, lung, and liver failure. Organ Care System The Organ Care System uses portable extracorporeal warm perfusion to preserve donor organs in a functioning state outside the body. The platform also allows...
What is Transplant?
Organ Transplant Technology Company TransMedics develops technology and services intended to expand access to donor organs for patients with end-stage heart, lung, and liver failure.
What is Technology?
Organ Transplant Technology Company TransMedics develops technology and services intended to expand access to donor organs for patients with end-stage heart, lung, and liver failure.